Abstract:The purpose of this study was to screen differentially expressed genes and microRNAs in order to find a new target for the accurate diagnosis and effective therapy of alcoholic liver disease (ALD) at the gene and microRNA levels. The total RNA of liver tissues was extracted from four groups of patients, ten subjects each. Microarrays were utilized to detect differentially expressed genes and microRNAs. According to gene values, significance levels and false discovery rate with a random variance model, gene ontology (GO) and the Kyoto Encyclopedia of Genes and Genomes (KEGG) database, node genes and key microRNAs in networks were obtained and analyzed. A total of 878 differentially expressed genes and 26 microRNAs were found. In co-expression genetic networks, node genes modulating the network were Acyl-coenzyme A synthetase-3 (ACSF3), Frizzled-5 (FZD5), LOC727987 and C1orf222. In microRNA-gene networks, the key microRNAs were hsa-miR-570, hsa-miR-122, hsa-miR-34b, hsa-miR-29c, hsa-miR-922 and hsa-miR-185, which negatively regulated approximately 79 downstream target genes. In the course of ALD, we found 4 differentially expressed node genes and analyzed ACSF3 and FZD5. ACSF3 was significantly upregulated, and was involved in fatty acid and lipid metabolism and accelerated liver injury. These two genes were involved in fatty acids and lipid metabolism. FZD5 was downregulated and reduced the synthesis of membrane transport protein in the hepatic membrane and the membrane stability, and accelerated the liver cell apoptosis process. Six key microRNAs regulated numerous biological functions such as the immune response, the inflammatory response and glutathione metabolism. This finding provides valuable insight into the diagnosis and treatment of ALD.

Challenge and direction of research on alcoholic liver disease

Alcoholic Liver Disease in China: A Disease Influenced by Complex Social Factors That Should Not Be Neglected

Noncoding RNAs in Alcoholic Liver Disease

New insights into the bile acid-based regulatory mechanisms and therapeutic perspectives in alcohol-related liver disease

Guidelines of prevention and treatment for alcoholic liver disease (2018, China).

Recent Advances in Understanding of Pathogenesis of Alcohol-Associated Liver Disease

Alcohol and the mechanisms of liver disease

Pathogenic mechanisms and regulatory factors involved in alcoholic liver disease

Alcoholic Liver Disease. Are There Any Differences Between China and Western Countries in Clinical Features?

Animal Models of Alcoholic Liver Disease: Pathogenesis and Clinical Relevance.

The role of gut microbiota, exosomes, and their interaction in the pathogenesis of ALD

Alcohol-associated liver disease - a current overview

Analysis of Differentially Expressed Genes and Micrornas in Alcoholic Liver Disease

The similarities and differences between American and Chinese guidelines for alcoholic liver disease.

Is the Hypoxia-Inducible Factor-1 Alpha Mrna Expression Activated by Ethanol-Induced Injury, the Mechanism Underlying Alcoholic Liver Disease?

Alcohol-Associated Liver Disease Outcomes: Critical Mechanisms of Liver Injury Progression

Guidelines for the Diagnosis and Management of Alcoholic Liver Disease: Update 2010

Genotype of Ethanol Metabolizing Enzyme Genes by Oligonucleotide Microarray in Alcoholic Liver Disease in Chinese People.

Recent advances in alcohol-related liver disease (ALD): summary of a Gut round table meeting

Targeting Inflammation for the Treatment of Alcoholic Liver Disease.

New Drug Targets for Alcoholic Liver Disease